Products

Back Share This Page

UltraClean DHA Omega

Support for Brain Health and Cognitive Function

UltraClean® DHA Omega contains a high ratio of DHA to EPA to help maintain brain health.

UltraClean® DHA Omega contains a high ratio of DHA to EPA. DHA is highly concentrated in brain cells and maintains brain health and function as well as supporting cognitive function. UltraClean® DHA Omega maintains DHA and EPA levels in breastfeeding women and supports healthy foetal development.

Serving Type: Soft Capsule
Available in Sizes: 60 soft capsules Dosage: Adults: Take 1-2 capsules one to two times a day, or as professionally prescribed.

Where to buy

Product Features

  • Supports brain health and brain function.
  • Maintains cognitive function.
  • Supports healthy foetal development.
  • Supports eye health.
  • UltraClean® DHA Omega helps to maintain omega-3 levels in breastfeeding women.

Ingredients

Concentrated omega-3 triglycerides - fish 1 g
equiv. to docosahexaenoic acid (DHA)500 mg
equiv. to eicosapentaenoic acid (EPA)100 mg

Warning

  • Always read the label. Follow the directions for use.
  • Nutritional supplements can only be of assistance if dietary intake is inadequate.
  • Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester.
  • Contains fish products, sulfites and soya bean products (lecithin). 
  • If you have any pre-existing conditions or are on any medications always talk to your health professional before use.
  • Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.

Evidence

[1] Ramakrishnan U, Stein AD, Parra-Caberera S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010;31(2 Suppl):S108-116.
[2] Jensen CL, Voigt RG, Llorente AM, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatrics 2010, www.jpeds.com
[3] Imhoff-Kunsch B, Stein AD, Martorell R, et al. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics 2011;128(3), http://pediatrics.aappublications.org/content/early/2011/07/28/peds.2010-1386
[4] Wheaton DH, Hoffman DR, Locke KG, et al. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Arch Ophthalmol 2003;121(9):1269-1278.
[5] DHA (docosahexaenoic acid). Natural Medicines Comprehensive Database 2014. Viewed 30 May 2014, www.naturaldatabase.com
[6] Braun L, Cohen M. Herbs and natural supplements: an evidence-based guide, 3rd ed. Sydney: Churchill Livingstone Elsevier, 2010.
[7] Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr 2009;89(2):S678-S684.
[8] Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83(6 Suppl):S1467-S1476.
[9] Austria JA, Richard MN, Chahine MN, et al. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 2008;27(2):214-221.
[10] Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003;143(4 Suppl):S1-S8,
[11] Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003;111(1):e39-e44.
[12] Helland IB, Saugstand OD, Saarem K, et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006;19(7):397-406.
[13] Montgomery C, Speake BK, Cameron A, et al. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003;90(1):135-145.
[14] Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83(6):1337-1344.
[15] Dutta-Roy AK. Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta. Am J Clin Nutr 2000;71(1 Suppl):S315S-S322.
[16] Jensen CL. Effects of n-3 fatty acids during pregnancy and lactation. Am J Clin Nutr 2006;83(6 Suppl):S1452-S1457.
[17] Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006;163(6):969-978.
[18] Uauy R, Dangour AD. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006;64(5 Pt 2):S24-S33.
[19] Larque E, Demmelmair H, Koletzko B. Perinatal supply and metabolism of long-chain polyunsaturated fatty acids: importance for the early development of the nervous system. Ann N Y Acad Sci 2002;967:299-310.

Educational Materials

EPA/ DHA - The Intelligence of Fish Oil
Informative description, investigation and treatment on EPA/DHA - "The Intelligence of Fish Oil".


Conditions Associated


Dietary Influence


Customers who bought this also purchased


Please tell us your email address

Submit Cancel

That is an invalid email address

Quantity Required


Login Page Desktop Version